Your Medication Management Partner
Unlocking better outcomes through precision health technology.
Evolving how we
prescribe medicine
Our understanding of genetics is changing how we prescribe. As the science of medicine evolves, we feel a responsibility to deliver solutions that keep pace with that change.
Our innovative, precision health technology can unlock the ability to deliver personalized treatment. Together we can improve quality, reduce costs, and increase overall satisfaction of care.
Optimizing treatment can take us from harm to healing
Every year people are injured or abandon medications altogether due to side effects or lack of efficacy.
3.2MM
>50%
$528B
52%
Deliver targeted and personalized care
Genomind brings critical prescribing data into one integrated platform, so you can easily manage medications for individual patients or large populations with precision.
Pharmacogenetic (PGx) Testing
Assess your patient’s genetics to personalize dosing and medication choices.
Precision Medicine Software
Identify gene and drug interaction risks while dynamically adjusting to safer alternatives.
Precision Medicine Consults
Access PharmD and PhD experts for training staff, consultations, and more.
Population Health Assessment
Stratify patient populations based on risk for drug-drug and potential gene-drug interactions.
Coming Soon
Improving the patient care experience
Associated with reducing hospitalizations and individual healthcare costs
What's new in precision medicine
Learn in person, virtually, or at your own pace through our education platform, Genomind 360.
Evexia Diagnostics Partners with Genomind to Offer Cutting-Edge Pharmacogenetic Testing to Clinicians
Genomind’s new partnership with Evexia Diagnostics expands access to its pharmacogenetic testing, helping more clinicians personalize treatments and improve patient outcomes through genetic insights.
Genomind Launches First-of-Its-Kind Patient Report: Offering Patients an Easy-to-Understand View into Personalized Genetic Test Results
KING OF PRUSSIA, Pa.–(BUSINESSWIRE)–Genomind, a leader in medication management and personalized medicine through pharmacogenetics (PGx), is proud to announce the release of its innovative Patient
Scary Good or Just Scary? Al in Psychiatry
Join Genomind and guest speaker, Roy H. Perlis, MD, MSc, on a journey through cutting-edge applications and the potential impact of artificial intelligence on mental
